Diagnosing long COVID: Canadian researchers discover unique new clue – GLOBAL
October 13, 2022
Patients and physicians struggling to officially diagnose long COVID may be one step closer to an answer, thanks to new research from a team of Canadian scientists.
The researchers at Lawson Health Research Institute have discovered patients with post-COVID-19 condition, known as long COVID, have unique signs in their blood that show rapid changes in their blood vessels.
These signs, or biomarkers, are a tell-tale indication that a patient has long COVID — a finding that could help to develop concrete diagnosis methods for an illness that remains largely a mystery to physicians and scientists, says Dr. Douglas Fraser, a Lawson scientist who has been studying long COVID since 2020. He is also a critical care physician at London Health Sciences Centre.
Read more: https://globalnews.ca/news/9194036/long-covid-canada-researchers-diagnosis/
